COSMOSID, INC.
NGS bioinformatics platform for rapid microbial identification and characterization
- Sector
- Medtech
- Headquarters
- Rockville, MD
- Founded
- 2007
- Latest Form D
- $100K, Sep 2011
- Total capital
- $2.7M
- Federal grants
- $1.3M
- 2 awards · 2020–2021
- Rank in peer group#12 of 22
- Private capital raised
- $1.3M
- 2 Form D · last Sep 2011
- 181 months since last filing
- Federal contracts
- None on recordNo federal contract awards found.
- Granted patents
- 2
- 7 pending · first 2018
- Rank in peer group#5 of 22
Capital timeline
Latest events
- Federal grantDefense · Phase II · Field deployable handheld sequencing technology and bioinformatics system for rapid detection of pathogens, AMR, and virulence for clinical decision-making in a battlefield environment$1.1M
- Federal grantDefense · Phase I · Field deployable handheld sequencing technology and bioinformatics system for rapid detection of pathogens, AMR, and virulence for clinical decision-making in a battlefield environment$246K
- Private capital raisedForm D · SEC · 2nd filing$100K
- Private capital raisedForm D · SEC · 1st filing$1.2M
Node area is scaled to amount. Form D reports securities sold, which can differ from an announced round; filings are numbered in the order they were made.
Standing among 22 peers
Line = medianMedtech · System
- Federal grantsBelow median
- Granted patents#5 · top 23%
Cumulative measures favor older companies. Rankings describe position today, not outcome. Below the median, ranks show as a band rather than a number.
Founders and team
Researcher links verified by same-company patents and grants- Rita ColwellResearcherExecutive Officer, DirectorLinked by 2 patents · $1.3M in grants as PI
- Bernard A. DavidDirectorNamed in SEC Form D filings
- Bill HarmonDirectorNamed in SEC Form D filings
- Coleman A. BurkeDirectorNamed in SEC Form D filings
- Doug BrennerExecutive Officer, DirectorNamed in SEC Form D filings
- Elliot MasieDirectorNamed in SEC Form D filings
Show all 10 people
- Jennifer A. MacKenzieDirectorNamed in SEC Form D filings
- Rod A. FratesDirectorNamed in SEC Form D filings
- Thomas A. CebulaExecutive OfficerNamed in SEC Form D filings
- Thomas A. StagnaroDirectorNamed in SEC Form D filings
What it has protected
USPTO · 2 granted of 9- PendingCreation Or Use Of Anchor-based Data Structures For Sample-derived Characteristic DeterminationUSPTOApplication 19047193
- PendingCreation Or Use Of Anchor-based Data Structures For Sample-derived Characteristic DeterminationUSPTOApplication 16853712
- PendingMethod And System For Genome IdentificationUSPTOApplication 16168618
Show all 9 patent records
- Creation Or Use Of Anchor-based Data Structures For Sample-derived Characteristic DeterminationJun 5, 2025 · Application 19047193Pending
- Creation Or Use Of Anchor-based Data Structures For Sample-derived Characteristic DeterminationSep 17, 2020 · Application 16853712Pending
- Method And System For Genome IdentificationSep 26, 2019 · Application 16168618Pending
- Method And System For Genome IdentificationOct 23, 2018 · US 10,108,778Granted
- Direct Identification And Measurement Of Relative Populations Of Microorganisms With Direct Dna Sequencing And Probabilistic MethodsAug 7, 2018 · US 10,042,976Granted
- Characterization Of Biological Material In A Sample Or Isolate Using Unassembled Sequence Information, Probabilistic Methods And Trait-specific Database CatalogsSep 25, 2014 · Application 13836139Pending
- Genome Identification SystemApplication PCTUS2008084403Pending
- Characterization Of Biological Material In A Sample Or Isolate Using Unassembled Sequence Information, Probabilistic Methods And Trait-specific Database CatalogsApplication PCTUS2014028980Pending
- Direct Identification And Measurement Of Relative Populations Of Microorganisms With Direct Dna Sequencing And Probabilistic MethodsApplication PCTUS2012022513Pending
Related companies, and why
- Amend Surgical, Inc.Similar federal contract value in Medtech · null in contracts
- Codetta Bio Inc.Similar federal contract value in Medtech · null in contracts
- PASCAL MEDICAL CORPORATIONSimilar federal contract value in Medtech · null in contracts
- CRYOLIFE INCSimilar federal contract value in Medtech · null in contracts
- Native Cardio, Inc.Similar federal contract value in Medtech · null in contracts
- Valar Labs, Inc.Similar federal contract value in Medtech · null in contracts
Regulatory activity · Medtech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.
Sources
Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.
How to read this page
Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.
Data freshness
SEC Form D filings through . SBIR and STTR awards through .